| Carboxyterminal degradation products of type I collagen | ||
|---|---|---|
| Prev | ||
Aibe K, Yazawa H, Abe K, Teramura K, Kumegawa M, Kawashima H & Honda K (1996) Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull 19:1026-1031.
Apone S, Lee MY & Eyre DR (1997) Osteoclast generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone. Bone 21:129-136.
Aruga A, Kolzumi M, Hotta R, Takahashi S & Ogata E (1997) Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer. Br J Cancer 76:760-764.
Atley LM, Mort JS, Lalumiere M & Eyre DR (2000) Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating the cross-linked N-telopeptide neoepitope. Bone 26:241-247.
Banda MJ & Werb Z (1981) Mouse macrophage elastase. Purification and characterization as a metalloproteinase. Biochem J 193:589-605.
Barber M, Bordoli RS, Elliott GJ, Fujimoto D & Scott JE (1982) The structure of pyridinolines. Biochem Biophys Res Comm 109:1041-1046.
Bartlett JD, Simmer JP, Xue J, Margolis HC & Moreno EC (1996) Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene 183:123-128.
Berti PJ & Storer AC (1995) Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol 246:273-283.
Bjarnason NH & Christiansen C (2000) Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women. Bone 26:561-569.
Blair HC, Kahn AJ, Crouch EC, Jeffrey JJ & Teitelbaum SL (1986) Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol 102:1164-1172.
Blair HC, Teitelbaum, SL, Grosso LE, Lacey DL, Tan HL, McCourt DW & Jeffreys JJ (1993) Extracellular-matrix degradation at acid pH. Avian osteoclast acid collagenase isolation and characterization. Biochem J 290:873–884.
Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD & Christiansen C (1997) Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 12:1028-1034.
Bonde M, Qvist P, Fledelius C, Riis BJ & Christiansen C (1994) Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022-2025.
Bossard MJ, Thomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M & Levy MA (1996) Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation and substrate identification. J Biol Chem 271:12517-12524.
Blonqvist C, Risteli L, Risteli J, Virkkunen P, Sarna S & Elomaa I (1996) Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Brit J Cancer 73:1074-1079.
Breathnach R, Matrisian LM, Gesnel MC, Staub A & Leroy P (1987) Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res 15:1139-1151.
Brömme D & Okamoto K (1995) Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary: Molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe-Seyler 376:379-384.
Brömme D, Okamoto K, Wang B & Biroc S (1996) Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. J Biol Chem 271:2126-2132.
Burjanadze TV (2000) New analysis of the phylogenetic change of collagen thermostability. Biopolymers 53:523-528.
Busiek DF, Ross FP, McDonnell S, Murphy G, Matrisian LM & Welgus HG (1992) The matrix metalloprotease matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem 267:9087-9092.
Calvo MS, Eyre DR & Gundberg CM (1996) Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev 17:333-368.
Chapman HA, Riese RJ & Shi GP (1997) Emerging roles for cysteine proteinases in human biology. Annu Rev Physiol 59:63-88.
Cheung DT, DiCesare P, Benya PD, Libaw E & Nimni ME (1983) The presence of intermolecular disulfide cross-links in type III collagen. J Biol Chem 258:7774-7778.
Chin JR, Murphy G & Werb Z (1985) Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization and substrates. J Biol Chem 260:12367-12376.
Christgau S, Rosenqvist C, Alexandersen P, Hannover Bjarnason N, Ravn P, Fledelius C (1998) Clinical evaluation of the serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone derived degradation products of type I collagen C-telopeptides. Clin Chem 44:2290-2300.
Chu ML, de Wet W, Bernard M, Ding JF, Morabito M, Myers J, Williams C & Ramirez F (1984) Human pro alpha 1(I) collagen gene structure reveals evolutionary concervation of a pattern of introns and exons. Nature 310:337-340.
Cole AA, Chubinskaya S, Schumacher M, Huch K, Cs-Szabo G, Yao J, Mikecz K, Hasty KA & Kuettner KE (1996) Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 271:11023-11026.
Collier IE, Bruns GA, Goldberg GI & Gerhard DS (1991) On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes. Genomics 9:429-434.
Colwell A & Eastell R (1996) Renal clearance of free and conjugated pyridinium crosslinks of collagen. J Bone Miner Res 11:1976-1980.
Clark IM & Murphy G (1999) Matrix proteinases. In: Dynamics of bone and cartilage metabolism. Academic Press. 672s.
Crazer R (2000) Extracellular matrix (ECM) components in a very primitive multicellular animal, the dicyemid mesozoan Kantharella antarctica. Anat Rec 259:52-59.
Curran S & Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300-308.
Delaisse JM, Boyde A, Maconnachie E, Ali NN, Sear CHJ, Eeckhout Y, Vaes G & Jones SJ (1987) The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305-313.
Delaisse JM, Ledent P & Vaes G (1991) Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem J 279:167-174.
Delaisse JM, Eeckhout Y & Vaes G (1984) In vivo and in vitro evidence for the involvement of cysteine proteinas in bone resorption. Biochem Biophys Res Commun 125:433-440.
Delaisse J-M, Engsig MT, Everts V, Ovejero MC, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkegaard T, Lenhard T, Heegaard A-M, Neff L, Baron R & Foged NT (2000) Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta 291:223-234.
Dodds RA, Connor JR, Drake F, Field J & Gowen M (1998) Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development. J Bone Miner Res 13:673-682.
Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G & Gowen M (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516.
Drake F, James I, Connor J, Rieman D, Dodds R, McCabe F, Bertolini D, Barthlow R, Hastings G & Gowen M (1994) J Bone Miner Res 9, S177.
Eastell R, Colwell A, Hapton L & Reeve J (1997) Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res 12:59-65.
Elomaa I, Virkkunen P, Risteli L & Risteli J (1992) Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 66:337-341.
Engel J & Prockop DJ (1991) The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. Annu Rev Biophys Chem 20:137-152.
Everts V, Saftig P, Korper W, Delaisse JM, Brömme D & Beertsen W (1999) Cathepsin K is more essential for long bone resorption than for resorption of calvarial bone. J Bone Miner Res 14:S356.
Exposito JY, D"Alessio M, Solursh M & Ramirez F (1992) Sea urchin collagen evolutionarily homologous to vertebrate pro-alpha 2(I) collagen. J Biol Chem 267:15559-15562.
Eyre DR, Paz MA & Gallop PM (1984) Cross-linking in collagen and elastin. Ann Rev Biochem 53:717-748.
Fields C (1988) Domain organization and intron positions in Caenorhabditis elegans collagen genes: the 54-bp module hypothesis revisited. J Mol Evol 28:55-63.
Fledelius C, Johnsen AH, Cloos PAC, Bonde M & Qvist P (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a β -isomerized asp-gly sequence within the C-terminal telopeptide (α1) region. J Biol Chem 272:9755-9763.
Freije JMP, Diez-Idra I, Balbin M, Sanchez LM, Blasco R, Tolivia J & Lopez-Otin C (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16766-16773.
Fujimoto D, Akiba KI & Nakamura N (1977) Isolation and characterization of a fluorescent material in bovine achilles tendon collagen. Biochem Biophys Res Commun 76:1124-1129.
Fujimoto D, Moriguchi T, Ishida T & Hayashi H (1978) The structure of pyridinoline, a collagen crosslink. Biochem Biophys Res Commun 84:52-57.
Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD & Delaisse JM (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347-32352.
Garnero P, Gineyts E, Arbault P, Christiansen C & Delmas PD (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-link excretion. J Bone Miner Res 10:641-649.
Garnero P, Shih WJ, Gineyts E, Karpf DB & Delmas PD (1994) Comparison of new biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationship between measurements of the different forms of pyridinoline cross-links. J Clin Endocrinol Metab 79:1693-1700.
Gelb BD, Shi GP, Chapman HA & Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA & Eisen AZ (1986) Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 261:6600-6605.
Gowen M, Lazner F, Dodds R, Kapadia R, Field J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzok P, Debouck C & Kola I (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663.
Gross J, Harper E, Harris ED, McCroskery PA, Highberger JH, Corbett C & Kang AH (1974) Animal collagenases: specificity of action, and structures of the substrate cleavage site. Biochem Biophys Res Commun 61: 605-612.
Hakala M, Risteli J, Manelius J, Nieminen P & Risteli J (1993) Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis 52:866-869.
Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, Van Hinsbergh VWH, Helaakoski T, Kainulainen T, Rönkä H, Tschesche H & Salo T (1997) Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J Biol Chem 272:31504-31509.
Hanson DA & Eyre DR (1996) Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem 271:26508-26516.
Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR & Eyre DR (1992) A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258.
Hassager C, Jensen LT, Pødenphant J, Thomsen K & Christiansen C (1994) The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int 54:30-33.
Hassager C, Risteli J, Manelius J, Nieminen P & Risteli J (1994) Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Osteopor Int 4:349-352.
Helseth DL & Veis A (1984) Cathepsin D-mediated processing of procollagen: Lysosomal enzyme involvement in secretory processing of procollagen. Proc Natl Acad Sci USA 81:3302-3306.
Henkel W, Glanville RW & Greifendorf D (1987) Characterization of a type I collagen trimeric cross-linked peptide from calf aorta and its cross-linked structure. Eur J Biochem 165:427-436.
Hidalgo M & Ekchardt SG (2001) Development of matrix metalloproteinase inhibitors in cancer therapy. J Nat Cancer Inst 93:178-193.
Ho N, Punturieri A, Wilkin D, Szabo J, Johnson M, Whaley J, Davis J, Clark A, Weiss S & Francomano C (1999) Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein. J Bone Miner Res 14:1649-1653.
Hoshi K, Kemmotsu S, Takeuchi Y, Amizuka N & Ozawa H (1999) The primary calcification in bones follows removal of decorin and fusion of collagen fibrils. J Bone Miner Res 14:273-280.
Hou WS, Bromme D, Zhao Y, Mehler E, Dushey C, Weinstein H, Miranda CS, Fraga C, Greig F, Carey J, Rimoin DL, Desnick RJ & Gelb BD (1999) Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest 103:731-738.
Housley T, Tanzer ML, Henson E & Gallop PM (1975) Collagen cross-linking: isolation of hydroxyaldol-histidine, a naturally-occurring crosslink. Biochem Biophys Res Commun 67:824-830.
Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M & Kokubo T (1995) Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206: 89- 96.
Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T & Yamamura T (1997) Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 272:8109-8112.
Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U & Kähäri VM (1997a) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151:499-508.
Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J & Kähäri VM (1997b) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208:387-397.
Johansson N, Westermarck J, Leppä S, Häkkinen L, Koivisto L, Lopez-Otin C, Peltonen J, Heino J & Kähäri VM (1997c) Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ 8:243-250.
Johnson M, Polymeropoulos M, Vos H, de Ortiz Luna R & Francomano C (1996) A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis. Genome Res 6:1050-1055.
Jukkola A, Tähtelä R, Tholix E, Vuorinen K, Blanco G, Risteli L & Risteli J (1997) Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP. Cancer Res 57:5517-5520.
Kadler KE, Holmes DF, Trotter JA & Chapman JA (1996) Collagen fibril formation. Review article. Biochem J 361: 1-11.
Kadler KE (1995) Type I collagen (Collagen I). In Protein Profile, Volume 2, Extracellular Matrix 1, pages 524-535. Academic Press
Kafienah W, Brömme D, Buttle DJ, Croucher LJ & Hollander AP (1998) Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331:727-732.
Kameyama O, Nakahigashi Y, Nakao H, Uejima D & Tsuji H (2000) Activity of rheumatoid arthritis and urinary pyridinoline and deoxypyridinoline. J Orthop Sci 5:385-389.
Kamiya T, Kobayashi Y, Kanaoka K, Nakashima T, Kato Y, Mizuno A, & Sakai H (1998) Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem 123: 752-759.
Karelina TV, Golberg GI & Eisen AZ (1994) Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J Invest Dermatol 103:482-487.
Kimura S (1983) Vertebrate skin type I collagen: comparison of bony fishes with lamprey and calf. Comp Biochem Physiol B 74:525-528.
Kivirikko KE, Laitinen O & Prockop DJ (1967) Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19:249-255.
Konttinen YT, Li TF, Mandelin J, Liljeström M, Sorsa T, Santavirta S & Virtanen I (2000) Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid arthritis. Arthritis Rheum 43:275-280.
Kuboki Y, Tsuzaki M, Sasaki S, Liu CF & Mechanic GL (1981) Location of the intermolecular cross-links in bovine dentin collagen, solubilization with trypsin and isolation of cross-link peptides containing dihydrolysinonorleucine and pyridinoline. Biochem Biophys Res Commun 102:119-126.
Kuypers R, Tyler M, Kurth LB, Jenkins ID & Horgan D (1992) Identification of the loci of the collagen associated Ehrlich chromogen in type I collagen confirms its role as a trivalent cross-link. Biochem J 283:129-136.
Kylmälä T, Tammela TLJ, Risteli L, Risteli J, Kontturi M & Elomaa I (1995) Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer. Brit J Cancer 71:1061-1064.
LaLonde JM, Zhao B, Janson JA, D’Alessio KJ, McQueney MS, Orsini MJ, Debouck CM & Smith WW (1999) The crystal structure of human procathepsin K. Biochemistry 38:862-869.
Lauer-Fields JL, Tuzinski KA, Shimokawa K, Nagase H & Fields GB (2000) Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases. J Biol Chem 275:13282-13290.
Lerner UH & Grubb A (1992) Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J Bone Miner Res 7:433-439.
Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A & Lopez-Otin C (1997) Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 40:1391-1399.
Lefebvre O, Wolf C, Limacher JM, Hutin P, Wendling C, LeMeur M, Basset P & Rio MC (1992) The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol 119:997-1002.
Li YP, Alexander M, Wucherpfennig AL, Yelick P, Chen W & Stashenko P (1995) Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Miner Res 10:1197-2202.
Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, Kokubo T, Inaoka T, Sloane J, Evans DB & Gallagher JA (1997) The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 57:5386-5390. (B)
Littlewood-Evans A, Kokubo R, Ishibashi O, Inaoka T, Wlodarski B, Gallagher JA & Bilbe G (1997) Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81-86. (A)
Llano E, Pendas AM, Freije JP, Nakano A, Knäuper V, Murphy G & Lopez-Otin C (1999) Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase overexpressed in brain tumors. Cancer Res 59:2570-2576.
Llano E, Pendas AM, Knäuper V, Sorsa T, Salo T, Salido E, Murphy G, Simmer JP, Bartlett JD & Lopez-Otin C (1997) Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36:15101-15108.
Lohi J, Wilson CL, Roby JD & Parks WC (2001) Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 274:10134-10144.
Mechanic GL, Gatz EP, Hemni M, Noyes C & Yamauchi M (1987) Locus of a histidino-based, stable trifunctional, helix to helix collagen cross-link: stereospecific collagen structure of type I skin fibrils. Biochemistry 26:3500-3509.
Melkko J, Kauppila S, Risteli L, Haukipuro K, Jukkola A & Risteli J (1996) Immunoassay for the intact aminoterminal propeptide of human type I procollagen (PINP). Clin Chem 42:947-54.
Melkko J, Niemi S, Risteli L & Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332.
Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF & Hambor JE (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97:761-768.
Monboisse J-C, Bellon G, Randoux A, Dufer J & Borel J-P (1990) Activation of human neutrophils by type I collagen. Biochem J 270:459-462.
Montcourrier P, Mangeat PH, Salazar G, Morisset M, Sahuquet A & Rochefort H (1990) Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 50:6045-6054.
Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ & Gelb BD (1999) Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. J Bone Miner Res 14:1902-1908.
Nomura H, Sato H, Seiki M, Mai M & Okada Y (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55:3263-3266.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M & Okada Y (1997) Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446-2451.
Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P & Basset P (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci U S A 92:2730-2734.
Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H & Seiki M (1995) Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 72:311-322.
Orgel JP, Wess TJ & Miller A (2000) The in situ conformation and axial location of the intermolecular cross-linked non-helical telopeptides of type I collagen. Structure 8:137-142.
Ottl J, Gabriel D, Murphy G, Knauper V, Tominage Y, Nagase H, Kroger M, Tschesche H, Bode W & Moroder L (2000) Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol 7:119-132.
Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE & Sang QX (2000) Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 275:20540-20544.
Pedersen BJ, Ravn P & Bonde M (1998) Type I collagen C-telopeptide degradation products as bone resorption markers. J Clin Ligand Assay 21:118-127.
Pendas AM, Knäuper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G & Lopez-Otin C (1997) Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location and tissue distribution. J Biol Chem 272:4281-4286.
Prockop DJ, Kivirikko KI, Tudermann L & Guzman NA (1979) The biosynthesis of collagen and its disorders. New Engl J Med 301: 13-23 & 77-78.
Puente XS, Pendas AM, Llano E, Velasco G & Lopez-Otin C (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949.
Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI & Ward L (1996) Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationship between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 11:1176-1184.
Rantakokko J, Aro HT, Savontaus M & Vuorio E (1996) Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett 393:307-313.
Reponen P, Sahlberg C, Munaut C, Thesleff I & Tryggvason K (1994) High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:1091-1102.
Ripley C & Bienkowski RS (1997) Localization of procollagen I in the lysosome/endosome system of human fibroblasts. Exp Cell Res 236:147-154.
Risteli J, Elomaa I, Niemi S, Novamo A & Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640.
Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat AP & Risteli L (1988) Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 34:715-718.
Robins SP & Bailey AJ (1975) The chemistry of the collagen cross-links. The mechanism of stabilization of the reducible intermediate cross-links. Biochem J 149:381-385.
Robins SP, Shimokomaki M & Bailey AJ (1973) The chemistry of collagen cross-links. Age-related changes in the reducible components of intact bovine collagen fibres. Biochem J 131:771-780.
Royce PM & Barnes MJ (1985) Failure of highly purified lysyl hydroxylase to hydroxylate lysyl residues in the non-helical regions of collagen. Biochem J 230:475-480.
Rosenqvist C, Fledelius C, Christgau S, Pedersen BJ, Bonde M, Qvist P & Christiansen C (1998) Serum CrossLaps One Step ELISA; First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen. Clin Chem 44:2281-2289.
Rubinacci A, Melzi R, Zampino M, Soldarini A & Villa I (1999) Total and free deoxypyridinoline after acute osteoclast activity inhibition. Clin Chem 45:1510-1516.
Saarialho-Kere UK, Crouch EC & Parks WC (1995) Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 105:190-196.
Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Detlev Moritz J, Schu P & von Figura K (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K deficient mice. Proc Natl Acad Sci 95:13453-13458.
Sakurai Y, Sullivan M, & Yamada Y (1986) Alpha 1 type IV collagen gene evolved differently form fibrillar collagen genes. J Biol Chem 261:6654-6657.
Sato T, del Carmen Ovejero M, Hou P, Heegaard AM, Kumegawa M, Foged NT & Delaisse JM (1997) Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110:589-596.
Scott JE, Hughes EW & Shuttleworth A (1981) A collagen-associated Ehrlich chromogen: a pyrrolic cross-link? Biosci Rep 1:611-618.
Scott JE, Qian R, Henkel W & Glanville RW (1983) An Ehrlich chromogen in collagen cross-links. Biochem J 209:263-264.
Shapiro SD, Griffin GL, Gilbert DJ, Jenkins NA, Copeland NG, Welgus HG, Senior RM & Ley TJ (1992) Molecular cloning, chromosomal location, and bacterial expression of a murine macrophage metalloelastase. J Biol Chem 267:4664-4671.
Shapiro SD, Kobayashi DK & Ley TJ (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 268:23824-23829.
Shi GP, Chapman HA, Bhairi Sm, DeLeeuw C, Reddy VY & Weiss SJ (1995) Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 357: 129-134.
Siegel RC (1976) Collagen cross-linking. Synthesis of collagen cross-links in vitro with highly purified lysyl oxidase. J Biol Chem 251:5786-5792.
Sivaraman J, Lalumiere M, Menard R & Cygrel M (1999) Crystal structure of wild-type human procathepsin K. Protein Sci 8:283-290.
StClair EW, Mook SA, Wilkinson WE, Sanders L, Lang T & Greenwald RA (1998) A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis. J Rheumatol 25:1472-1479.
Stoltz M, Timpl R, Furthmayr H & Kühn K (1973) Structural and immunogenic properties of a major antigenic determinant in neutral salt-extracted rat-skin collagen. Eur J Biochem 37:287-294.
Sukhova GK, Shi GP, Simon DI, Chapman HA & Libby P (1998) Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102:576-583.
Suzuki M, Takahashi M, Miyamoto S, Hoshino H, Kushida K, Miura M & Inoue T (1998) The effects of menopausal status and disease activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. Brit J Dermatol 37:653-658.
Takino T, Sato H, Shinagawa A & Seiki M (1995) Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 270:23013-23020.
Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, Kawashima H, Eguchi H, Hakeda Y & Kumegawa M (1994) Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269:15006-15009.
Tezuka K, Sato T, Kamioka H, Niveide PJ, Tanaka K, Matsuo T, Ohta M, Kurihara N, Hakeda Y & Kumegava M (1992) Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 186: 911-917.
Tilson MD, Dreyer RN, Hudson A, Cotte RJ & Tanzer ML (1985) Partial characteristics of an analog of pyridinoline isolated from human skin. Biochem Biophys Res Comm 126:1222-1227.
Thompson SK, Halbert SM, Bossard MJ, Tomaszek TA, Levy MA, Zhao B, Smith WW, Abdel-Meguid SS, Janson CA, D’Alessio KJ, McQueney MS, Amegadzie BY, Hanning CR, DesJarlais RL, Briand J, Sarkar SK, Huddleston MJ, Ijames CF, Carr SA, Garnes KT, Shu A, Heys JR, Brdbeer J, Zembryki D, Lee-Rykaczewski L, James IE, Lark MW, Drake FH, Gowen M, Gleason JG & Veber DF (1997) Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci 94:14249-14254.
Uria JA & Lopez-Otin C (2000) Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency and activity. Cancer Res 60:4745-4751.
Valtavaara M, Papponen H, Pirttilä AM, Hiltunen K, Helander H & Myllylä R (1997) Cloning and characterization of a novel human lysyl hydroxylase isoform highly expressed in pancreas and muscle. J Biol Chem 272:6831-6834.
Velasco G, Gal S, Merlos-Suarez A, Ferrando AA, Alvarez S, Nakano A, Arribas J & Lopez-Otin C (2000) Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res 60:877-882.
Velasco G, Pendas AM, Fueyo A, Knäuper V, Murphy G & Lopez-Otin C (1999) Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 274:4570-4576.
Von Der Mark K (1999) Structure, biosynthesis, and gene regulation of collagens in cartilage and bone. Seibel MJ, Robins SP & Bilezikian JP (eds) Dynamics of bone and cartilage metabolism. Academic Press 1999, p 3-28.
Votta BJ, Levy MA, Badger A, Bradbeer J, Dodds RA, James IA, Thompson S, Bossard MJ, Carr T, Connor JR, Tomaszek TA, Szewczuk L, Drake FH, Veber DF & Gowen M (1997) Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res 12:1396-1406.
Wardale RJ & Duance VC (1993) Quantification and immunolocalisation of porcine articular and growth plate collagens. J Cell Sci 105:975-984.
Wernicke D, Seyfert C, Hinzmann B & Gromica-Ihle E (1996) Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 23:590-595.
Wichers M, Schmidt E, Bidlingmaier F & Klingmüller D (1999) Diurnal rhythm of CrossLaps in human serum. Clin Chem 45:1858-1860.
Wilhelm SM, Shao ZH, Housley TJ, Seperack PK, Baumann AP, Gunja-Smith Z & Woessner JF Jr (1993) Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloprotease and effect of pH on catalytic proterties and calcium affinity. J Biol Chem 268:21906-21913.
Will H & Hinzmann B (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608.
Wilson CL & Matrisian LM (1996) Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28:123-136.
Wucherpfennig AL, Li YP, Stetler-Stevenson WG, Rosenberg AE & Stashenko P (1994) Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res 9:549-556.
Yamauchi M, London RE, Guenat C, Hashimoto F & Mechanic GL (1987) Structure and formation of a stable histidino-based trifunctional cross-link in skin collagen. J Biol Chem 262:11428-11434.
Yamauchi M, Woodley DT & Mechanic GL (1988) Aging and cross-linking of skin collagen. Biochem Biophys Res Comm 152:898-903.
Yamaza T, Goto T, Kamiya T, Kobayashi Y, Sakai H & Tanaka T (1998) Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23:499-509.
Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K & Okada Y (2000) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 59:455-461.